QuickView for YDL103C;jsessionid=15F15BB478DC6C77651BC16CE76A6F8A;jsessionid=FA09DD4A5D65571BA1AD979499E356E2;jsessionid=5DB5107377C50D220B2B02849FAC3A0E;jsessionid=161EA4FB6A70DC430F4519468CC7F620;jsessionid=696890CAB45EBF2E3C87D2130F1D510F;jsessionid=B10D9C0D3170F704C6ACD5A7045EC88F;jsessionid=66EB107631F295A321D01D76B696806C;jsessionid=E6613F4FD66F4AEEA7138003B955CF09;jsessionid=604C2E636A4F0C714D32EDE7995E5EC4;jsessionid=D6A0F57CE66CAC852DED06D67BE43398 (gene)

1. Cyst fluid glycoproteins accurately distinguishing malignancies of pancreatic cystic neoplasm.
2. Clinical Evaluation of Cystic Renal Masses With Bosniak Classification by Contrast-Enhanced Ultrasou…
3. Feasibility of Surveillance for Mucinous Cystic Neoplasm of the Pancreas: A Multi-Institutional Retr…
4. Clinicopathological and genetic characteristics of congenital cystic adenomatoid malformation of lun…
5. The added value of contrast-enhanced ultrasound in evaluation of indeterminate small solid renal mas…

There were no clinical trials for YDL103C;jsessionid=15F15BB478DC6C77651BC16CE76A6F8A;jsessionid=FA09DD4A5D65571BA1AD979499E356E2;jsessionid=5DB5107377C50D220B2B02849FAC3A0E;jsessionid=161EA4FB6A70DC430F4519468CC7F620;jsessionid=696890CAB45EBF2E3C87D2130F1D510F;jsessionid=B10D9C0D3170F704C6ACD5A7045EC88F;jsessionid=66EB107631F295A321D01D76B696806C;jsessionid=E6613F4FD66F4AEEA7138003B955CF09;jsessionid=604C2E636A4F0C714D32EDE7995E5EC4;jsessionid=D6A0F57CE66CAC852DED06D67BE43398